World Thalassemia Day: RGCIRC promotes shift from transfusion to transplant
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Subscribe To Our Newsletter & Stay Updated